| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR9G1 PECAM1 ROR2 OR2L5 OR2G3 OR2C3 FGFRL1 OR2J1 OR6C68 ADGRE2 CR1 EDA OR9G9 OR2C1 OR2B11 FCGR2C FCGR1BP FCGR2B PTPRZ1 OR6C4 SORCS2 ROBO2 ADGRE5 FGFR2 FGFR4 KIR2DS1 TM2D1 MUSK TMEM63A | 1.57e-09 | 1353 | 121 | 29 | GO:0004888 |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 2.15e-06 | 5 | 121 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 ADGRE2 PCDHB16 CEMIP2 RYR3 PCDHB18P MYOF HMCN1 ADGRE5 | 2.77e-06 | 749 | 121 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | IgG receptor activity | 7.46e-06 | 7 | 121 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 2.02e-05 | 27 | 121 | 4 | GO:0017134 | |
| GeneOntologyMolecularFunction | IgG binding | 3.46e-05 | 11 | 121 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.65e-05 | 65 | 121 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 7.52e-05 | 14 | 121 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.68e-04 | 85 | 121 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 OR2C1 OR2B11 OR6C4 | 2.97e-04 | 431 | 121 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 ADGRE2 OR9G9 OR2C1 OR2B11 OR6C4 SORCS2 ADGRE5 TM2D1 | 9.33e-04 | 884 | 121 | 14 | GO:0004930 |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.34e-03 | 36 | 121 | 3 | GO:0019865 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PECAM1 PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 NECTIN3 PCDHB16 PCDHB18P HMCN1 ROBO2 | 4.39e-13 | 187 | 124 | 15 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PECAM1 PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 FGFRL1 NECTIN3 PCDHB16 PCDHB18P HMCN1 ROBO2 | 6.70e-11 | 313 | 124 | 16 | GO:0098742 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 9.60e-10 | 53 | 124 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH ZAN PECAM1 PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 EMILIN2 PCDHB3 PCDHB2 LAMA3 FGFRL1 NECTIN3 CR1 PDIA3 PCDHB16 PCDHB18P MALT1 HMCN1 STXBP6 ROBO2 | 2.27e-08 | 1077 | 124 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | synapse assembly | PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB6 PCDHB3 PCDHB2 NECTIN3 ADGRE2 PCDHB16 ROBO2 ADGRE5 MUSK | 4.44e-08 | 308 | 124 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | cell junction assembly | PECAM1 PCDHB14 CAPZA1 PCDHB11 PCDHB10 PCDHB9 PCDHB6 PCDHB3 PCDHB2 LAMA3 NECTIN3 ADGRE2 PCDHB16 ROBO2 ADGRE5 MUSK | 3.16e-07 | 569 | 124 | 16 | GO:0034329 |
| GeneOntologyBiologicalProcess | synapse organization | ROR2 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB6 PCDHB3 PCDHB2 NECTIN3 ADGRE2 PCDHB16 SEMA3A FCGR2B ROBO2 ADGRE5 FGFR2 MUSK | 7.52e-07 | 685 | 124 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | PECAM1 ROR2 PCDHB14 CAPZA1 PCDHB11 PCDHB10 PCDHB9 PCDHB6 PCDHB3 PCDHB2 LAMA3 NECTIN3 ADGRE2 PCDHB16 SEMA3A FCGR2B ROBO2 ADGRE5 FGFR2 MUSK | 1.42e-06 | 974 | 124 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell recognition | 3.16e-06 | 198 | 124 | 9 | GO:0008037 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 4.50e-06 | 19 | 124 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | immune complex clearance | 1.74e-05 | 9 | 124 | 3 | GO:0002434 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.96e-05 | 27 | 124 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 3.04e-05 | 60 | 124 | 5 | GO:0002920 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.48e-05 | 12 | 124 | 3 | GO:0002924 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 5.80e-05 | 13 | 124 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | complement activation | 6.41e-05 | 70 | 124 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 7.35e-05 | 14 | 124 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 8.92e-05 | 235 | 124 | 8 | GO:0016064 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 9.15e-05 | 15 | 124 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 9.15e-05 | 15 | 124 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.12e-04 | 16 | 124 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.12e-04 | 16 | 124 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 1.14e-04 | 79 | 124 | 5 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 1.14e-04 | 79 | 124 | 5 | GO:0002889 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 1.16e-04 | 244 | 124 | 8 | GO:0019724 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 1.17e-04 | 42 | 124 | 4 | GO:0002438 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.92e-04 | 19 | 124 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 WDR47 OR2C1 OR2B11 CACNA2D4 OR6C4 | 2.05e-04 | 582 | 124 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception | CFH OR9G1 OR2L5 OR2G3 SLC26A5 OR2C3 OR2J1 OR6C68 OR9G9 BBS10 WDR47 OR2C1 OR2B11 CACNA2D4 COCH HMCN1 OR6C4 | 2.34e-04 | 1072 | 124 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 OR2C1 OR2B11 OR6C4 | 2.86e-04 | 432 | 124 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 3.00e-04 | 22 | 124 | 3 | GO:0002923 | |
| GeneOntologyBiologicalProcess | neuron recognition | 4.39e-04 | 59 | 124 | 4 | GO:0008038 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 4.43e-04 | 25 | 124 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 OR2C1 OR2B11 OR6C4 | 5.09e-04 | 465 | 124 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 5.29e-04 | 6 | 124 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 5.30e-04 | 62 | 124 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | ribosomal large subunit assembly | 6.22e-04 | 28 | 124 | 3 | GO:0000027 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 OR2C1 OR2B11 OR6C4 | 7.04e-04 | 485 | 124 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 7.38e-04 | 7 | 124 | 2 | GO:0030451 | |
| Domain | Cadherin_C | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 1.10e-13 | 42 | 121 | 10 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 1.10e-13 | 42 | 121 | 10 | PF16492 |
| Domain | Cadherin_2 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 1.18e-11 | 65 | 121 | 10 | PF08266 |
| Domain | Cadherin_N | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 1.18e-11 | 65 | 121 | 10 | IPR013164 |
| Domain | IGc2 | PECAM1 ROR2 FGFRL1 OPCML MFAP3L MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 MUSK MYBPC1 | 3.89e-10 | 235 | 121 | 14 | SM00408 |
| Domain | Ig_sub2 | PECAM1 ROR2 FGFRL1 OPCML MFAP3L MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 MUSK MYBPC1 | 3.89e-10 | 235 | 121 | 14 | IPR003598 |
| Domain | IG | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 1.88e-09 | 421 | 121 | 17 | SM00409 |
| Domain | Ig_sub | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 1.88e-09 | 421 | 121 | 17 | IPR003599 |
| Domain | Cadherin_CS | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 2.22e-09 | 109 | 121 | 10 | IPR020894 |
| Domain | CADHERIN_1 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 3.17e-09 | 113 | 121 | 10 | PS00232 |
| Domain | Cadherin | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 3.17e-09 | 113 | 121 | 10 | PF00028 |
| Domain | CADHERIN_2 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 3.45e-09 | 114 | 121 | 10 | PS50268 |
| Domain | - | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 3.45e-09 | 114 | 121 | 10 | 2.60.40.60 |
| Domain | CA | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 3.76e-09 | 115 | 121 | 10 | SM00112 |
| Domain | Cadherin-like | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 4.09e-09 | 116 | 121 | 10 | IPR015919 |
| Domain | Cadherin | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 | 4.84e-09 | 118 | 121 | 10 | IPR002126 |
| Domain | IG_LIKE | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 1.85e-08 | 491 | 121 | 17 | PS50835 |
| Domain | Ig-like_dom | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 2.63e-08 | 503 | 121 | 17 | IPR007110 |
| Domain | - | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 FNDC7 HMCN1 FCGR1BP FCGR2B PTPRZ1 ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 5.15e-08 | 663 | 121 | 19 | 2.60.40.10 |
| Domain | Ig-like_fold | PECAM1 ROR2 FGFRL1 NECTIN3 OPCML MFAP3L SEMA3A MALT1 FNDC7 HMCN1 FCGR1BP FCGR2B PTPRZ1 ROBO2 FGFR2 FGFR4 KIR2DS1 MUSK MYBPC1 | 1.37e-07 | 706 | 121 | 19 | IPR013783 |
| Domain | Ig_I-set | ROR2 FGFRL1 OPCML MFAP3L HMCN1 ROBO2 FGFR2 FGFR4 MUSK MYBPC1 | 4.46e-07 | 190 | 121 | 10 | IPR013098 |
| Domain | I-set | ROR2 FGFRL1 OPCML MFAP3L HMCN1 ROBO2 FGFR2 FGFR4 MUSK MYBPC1 | 4.46e-07 | 190 | 121 | 10 | PF07679 |
| Domain | ig | PECAM1 FGFRL1 OPCML SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B FGFR4 KIR2DS1 | 4.46e-07 | 190 | 121 | 10 | PF00047 |
| Domain | Immunoglobulin | PECAM1 FGFRL1 OPCML SEMA3A MALT1 HMCN1 FCGR1BP FCGR2B FGFR4 KIR2DS1 | 4.46e-07 | 190 | 121 | 10 | IPR013151 |
| Domain | GPCR_2_CD97 | 4.16e-05 | 2 | 121 | 2 | IPR003056 | |
| Domain | PCDHB2/3 | 4.16e-05 | 2 | 121 | 2 | IPR030735 | |
| Domain | WD40/YVTN_repeat-like_dom | TRAF7 VPS8 KATNB1 WDR47 SEMA3A SF3B3 DAW1 WDFY3 DCAF11 WIPI2 | 6.56e-05 | 335 | 121 | 10 | IPR015943 |
| Domain | WD40_repeat_dom | 1.37e-04 | 297 | 121 | 9 | IPR017986 | |
| Domain | Olfact_rcpt | OR9G1 OR2L5 OR2G3 OR2C3 OR2J1 OR6C68 OR9G9 OR2C1 OR2B11 OR6C4 | 2.41e-04 | 393 | 121 | 10 | IPR000725 |
| Domain | Neural_cell_adh | 2.48e-04 | 4 | 121 | 2 | IPR009138 | |
| Domain | FGF_rcpt_fam | 2.48e-04 | 4 | 121 | 2 | IPR016248 | |
| Domain | - | 3.21e-04 | 333 | 121 | 9 | 2.130.10.10 | |
| Domain | Sushi | 3.57e-04 | 52 | 121 | 4 | PF00084 | |
| Domain | WD40_repeat | 3.98e-04 | 272 | 121 | 8 | IPR001680 | |
| Domain | CCP | 4.13e-04 | 54 | 121 | 4 | SM00032 | |
| Domain | WD_REPEATS_1 | 4.59e-04 | 278 | 121 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.70e-04 | 279 | 121 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.70e-04 | 279 | 121 | 8 | PS50294 | |
| Domain | SUSHI | 4.75e-04 | 56 | 121 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.08e-04 | 57 | 121 | 4 | IPR000436 | |
| Domain | Ig_2 | 1.29e-03 | 73 | 121 | 4 | PF13895 | |
| Domain | - | 1.36e-03 | 74 | 121 | 4 | 3.40.50.410 | |
| Domain | CTLH | 1.45e-03 | 9 | 121 | 2 | SM00668 | |
| Domain | WD40 | 1.50e-03 | 259 | 121 | 7 | PF00400 | |
| Domain | CTLH_C | 1.81e-03 | 10 | 121 | 2 | IPR006595 | |
| Domain | CTLH | 1.81e-03 | 10 | 121 | 2 | PS50897 | |
| Domain | WD40 | 1.82e-03 | 268 | 121 | 7 | SM00320 | |
| Domain | VWFA | 1.99e-03 | 82 | 121 | 4 | PS50234 | |
| Domain | VWA | 2.17e-03 | 84 | 121 | 4 | SM00327 | |
| Domain | G-protein_beta_WD-40_rep | 2.27e-03 | 85 | 121 | 4 | IPR020472 | |
| Domain | Tyr_kinase_cat_dom | 2.57e-03 | 88 | 121 | 4 | IPR020635 | |
| Domain | TyrKc | 2.57e-03 | 88 | 121 | 4 | SM00219 | |
| Domain | PROTEIN_KINASE_TYR | 3.65e-03 | 97 | 121 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.65e-03 | 97 | 121 | 4 | IPR008266 | |
| Domain | VWF_A | 3.93e-03 | 99 | 121 | 4 | IPR002035 | |
| Domain | WD40_repeat_CS | 4.31e-03 | 164 | 121 | 5 | IPR019775 | |
| Domain | EGF-like_dom | 5.68e-03 | 249 | 121 | 6 | IPR000742 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 6.21e-05 | 69 | 86 | 5 | M16894 | |
| Pubmed | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 1.23e-22 | 20 | 124 | 11 | 11322959 | |
| Pubmed | 2.63e-17 | 13 | 124 | 8 | 12231349 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 1.21e-16 | 57 | 124 | 11 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 1.49e-16 | 58 | 124 | 11 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 9.71e-16 | 68 | 124 | 11 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 1.89e-15 | 72 | 124 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 2.60e-15 | 74 | 124 | 11 | 10817752 |
| Pubmed | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 4.12e-15 | 77 | 124 | 11 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 6.40e-15 | 80 | 124 | 11 | 10716726 |
| Pubmed | 3.18e-08 | 10 | 124 | 4 | 22969705 | ||
| Pubmed | Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. | 1.50e-07 | 14 | 124 | 4 | 19299737 | |
| Pubmed | A unique role of cohesin-SA1 in gene regulation and development. | 2.71e-07 | 16 | 124 | 4 | 22415368 | |
| Pubmed | 3.53e-07 | 17 | 124 | 4 | 18279309 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 4.40e-07 | 5 | 124 | 3 | 11566361 | |
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 8.78e-07 | 6 | 124 | 3 | 24026051 | |
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.53e-06 | 7 | 124 | 3 | 9182820 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.28e-06 | 59 | 124 | 5 | 23754746 | |
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 2.45e-06 | 8 | 124 | 3 | 2564419 | |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 3.41e-06 | 29 | 124 | 4 | 22424930 | |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 15229180 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 4.49e-06 | 31 | 124 | 4 | 22076636 | |
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 4.49e-06 | 31 | 124 | 4 | 19344414 | |
| Pubmed | Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. | 5.21e-06 | 10 | 124 | 3 | 8422330 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 2531080 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21659506 | ||
| Pubmed | Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. | 1.26e-05 | 2 | 124 | 2 | 19500394 | |
| Pubmed | Contradictory Role of CD97 in Basal and Tumor Necrosis Factor-Induced Osteoclastogenesis In Vivo. | 1.26e-05 | 2 | 124 | 2 | 26663852 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20084281 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20167235 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31969668 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23676664 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 2977721 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19717518 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18326527 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18182380 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17157600 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17158902 | ||
| Pubmed | Complement factor H and hemicentin-1 in age-related macular degeneration and renal phenotypes. | 1.26e-05 | 2 | 124 | 2 | 17591627 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23660400 | ||
| Pubmed | The role of the RGD motif in CD97/ADGRE5-and EMR2/ADGRE2-modulated tumor angiogenesis. | 1.26e-05 | 2 | 124 | 2 | 31594642 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24949957 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9516136 | ||
| Pubmed | CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells. | 1.26e-05 | 2 | 124 | 2 | 18603564 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18941248 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 14707087 | ||
| Pubmed | Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression. | 1.26e-05 | 2 | 124 | 2 | 27492604 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12829604 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34314469 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18267122 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10744645 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15498814 | ||
| Pubmed | 1.95e-05 | 15 | 124 | 3 | 28465335 | ||
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 2.39e-05 | 16 | 124 | 3 | 11489951 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 2.44e-05 | 47 | 124 | 4 | 14760718 | |
| Pubmed | 2.64e-05 | 162 | 124 | 6 | 25826454 | ||
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 19753101 | ||
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 26102480 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28056982 | ||
| Pubmed | Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. | 3.77e-05 | 3 | 124 | 2 | 12879061 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25349422 | ||
| Pubmed | Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1. | 3.77e-05 | 3 | 124 | 2 | 26723877 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 29669286 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25979949 | ||
| Pubmed | Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. | 3.77e-05 | 3 | 124 | 2 | 20131275 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 23447688 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 34298973 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11297558 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26133275 | ||
| Pubmed | The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion. | 3.77e-05 | 3 | 124 | 2 | 18061161 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 3782802 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 16885922 | ||
| Pubmed | Identification of a new fibroblast growth factor receptor, FGFR5. | 3.77e-05 | 3 | 124 | 2 | 11418238 | |
| Pubmed | Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. | 3.77e-05 | 3 | 124 | 2 | 27498393 | |
| Pubmed | Evidence for association between multiple complement pathway genes and AMD. | 3.77e-05 | 3 | 124 | 2 | 17266113 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20702729 | ||
| Pubmed | Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. | 3.77e-05 | 3 | 124 | 2 | 23261299 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 9988761 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 10540231 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 2165484 | ||
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 3.77e-05 | 3 | 124 | 2 | 24586589 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28923346 | ||
| Pubmed | Studies on the interactions between C-reactive protein and complement proteins. | 3.77e-05 | 3 | 124 | 2 | 17244159 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 33497605 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20051117 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 17449467 | ||
| Pubmed | 4.11e-05 | 19 | 124 | 3 | 16049112 | ||
| Pubmed | 4.11e-05 | 19 | 124 | 3 | 23920377 | ||
| Pubmed | ABCB7 MAEA VPS8 CAPZA1 L2HGDH PDIA3 DICER1 PDCD4 NKRF MYOF SF3B3 MDN1 GID4 NOP2 ALPI VDAC3 | 5.53e-05 | 1440 | 124 | 16 | 30833792 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9551950 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 27165610 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 27590203 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 31562320 | ||
| Pubmed | Fc receptor regulation of protective immunity against Chlamydia trachomatis. | 7.53e-05 | 4 | 124 | 2 | 11872097 | |
| Pubmed | MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development. | 7.53e-05 | 4 | 124 | 2 | 21969379 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9490697 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9212826 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 28028748 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 18406463 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 6967858 | ||
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 7.53e-05 | 4 | 124 | 2 | 36142417 | |
| Interaction | PCDHB3 interactions | ROR2 PCDHB10 PCDHB9 PCDHB7 PCDHB3 PCDHB2 NECTIN3 PCDHB16 PCDHB18P MYOF | 9.61e-09 | 141 | 117 | 10 | int:PCDHB3 |
| Interaction | PCDHB16 interactions | 1.28e-07 | 41 | 117 | 6 | int:PCDHB16 | |
| Interaction | PCDHB10 interactions | 6.56e-06 | 7 | 117 | 3 | int:PCDHB10 | |
| Interaction | PCDHB18P interactions | 3.34e-05 | 2 | 117 | 2 | int:PCDHB18P | |
| Cytoband | 5q31 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 1.99e-14 | 115 | 124 | 11 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 6.33e-10 | 298 | 124 | 11 | chr5q31 |
| Cytoband | 1q44 | 2.35e-04 | 110 | 124 | 4 | 1q44 | |
| Cytoband | 1q32 | 3.24e-04 | 49 | 124 | 3 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 4.18e-04 | 128 | 124 | 4 | chr1q44 | |
| Cytoband | 1p13.3 | 8.85e-04 | 69 | 124 | 3 | 1p13.3 | |
| GeneFamily | Clustered protocadherins | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB7 PCDHB6 PCDHB3 PCDHB2 PCDHB16 PCDHB18P | 6.15e-14 | 64 | 102 | 11 | 20 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | ROR2 FGFRL1 NECTIN3 OPCML MFAP3L HMCN1 ROBO2 FGFR2 FGFR4 MUSK MYBPC1 | 1.76e-09 | 161 | 102 | 11 | 593 |
| GeneFamily | Olfactory receptors, family 2 | 4.31e-05 | 113 | 102 | 6 | 149 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 7.46e-05 | 40 | 102 | 4 | 321 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | PECAM1 NECTIN3 ADGRE2 CR1 FCGR2C FCGR2B ADGRE5 FGFR2 FGFR4 KIR2DS1 | 7.72e-05 | 394 | 102 | 10 | 471 |
| GeneFamily | Immunoglobulin like domain containing | 1.11e-04 | 193 | 102 | 7 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.00e-04 | 57 | 102 | 4 | 1179 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 3.12e-04 | 5 | 102 | 2 | 915 | |
| GeneFamily | WD repeat domain containing | 7.10e-04 | 262 | 102 | 7 | 362 | |
| GeneFamily | Complement system|Sushi domain containing | 1.09e-03 | 36 | 102 | 3 | 492 | |
| GeneFamily | Olfactory receptors, family 9 | 7.38e-03 | 23 | 102 | 2 | 156 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 8.02e-03 | 24 | 102 | 2 | 654 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 3.91e-08 | 42 | 121 | 6 | MM1275 | |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 2.56e-07 | 93 | 121 | 7 | MM1266 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 1.27e-06 | 41 | 121 | 5 | M2000 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_UP | 1.45e-05 | 170 | 121 | 7 | M2168 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.06e-05 | 191 | 121 | 7 | MM17059 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN | 4.11e-05 | 200 | 121 | 7 | M9930 | |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 4.98e-05 | 86 | 121 | 5 | M1968 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 5.14e-05 | 16 | 121 | 3 | M40964 | |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_2500_k-means-cluster#3 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 PCDHB3 FCGR2C FCGR2B KBTBD12 | 1.36e-07 | 158 | 110 | 9 | PP_RBC_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | ROR2 PCDHB15 PCDHB11 PCDHB10 PCDHB3 ZNF521 PCDHB16 SEMA3A ABCG1 | 3.05e-06 | 229 | 110 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 6.17e-06 | 188 | 110 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 EMILIN2 PCDHB2 ZNF521 AASDH PDCD4 CEMIP2 BBS10 RING1 MALT1 MYOF CDK5RAP3 FGFR2 | 3.74e-05 | 1075 | 110 | 17 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | ERV3-1 ROR2 PCDHB15 PCDHB14 PCDHB11 PCDHB10 PCDHB9 EMILIN2 PCDHB2 ZNF521 FGFRL1 PDCD4 CEMIP2 BBS10 RING1 SEMA3A MYOF CDK5RAP3 FGFR2 TM2D1 | 5.84e-05 | 1466 | 110 | 20 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-09 | 188 | 122 | 9 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-09 | 188 | 122 | 9 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-08 | 183 | 122 | 8 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-08 | 186 | 122 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.93e-08 | 187 | 122 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.80e-08 | 191 | 122 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.04e-08 | 192 | 122 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.54e-08 | 194 | 122 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-08 | 194 | 122 | 8 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-08 | 196 | 122 | 8 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.00e-07 | 167 | 122 | 7 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.98e-07 | 185 | 122 | 7 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-07 | 189 | 122 | 7 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-07 | 190 | 122 | 7 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 9.53e-07 | 190 | 122 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.88e-07 | 191 | 122 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.88e-07 | 191 | 122 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 192 | 122 | 7 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 193 | 122 | 7 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 194 | 122 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 195 | 122 | 7 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.13e-06 | 195 | 122 | 7 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 196 | 122 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.17e-06 | 196 | 122 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.21e-06 | 197 | 122 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.21e-06 | 197 | 122 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-06 | 197 | 122 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.21e-06 | 197 | 122 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.26e-06 | 198 | 122 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-06 | 198 | 122 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-06 | 198 | 122 | 7 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.30e-06 | 199 | 122 | 7 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.30e-06 | 199 | 122 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 199 | 122 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 199 | 122 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.34e-06 | 200 | 122 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-06 | 200 | 122 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.34e-06 | 200 | 122 | 7 | bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.34e-06 | 200 | 122 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-06 | 200 | 122 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-06 | 200 | 122 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-06 | 200 | 122 | 7 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Sigmoid / Region, Cell class and subclass | 1.34e-06 | 200 | 122 | 7 | 851a1b372ddbec522829069e69ed36a1f4832131 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-06 | 200 | 122 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.25e-06 | 154 | 122 | 6 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 5.11e-06 | 159 | 122 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.89e-06 | 163 | 122 | 6 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.10e-06 | 164 | 122 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 166 | 122 | 6 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 166 | 122 | 6 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 166 | 122 | 6 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 166 | 122 | 6 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-06 | 166 | 122 | 6 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-06 | 168 | 122 | 6 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 168 | 122 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-06 | 168 | 122 | 6 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-06 | 168 | 122 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.28e-06 | 173 | 122 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 174 | 122 | 6 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 174 | 122 | 6 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-06 | 174 | 122 | 6 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 176 | 122 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-06 | 176 | 122 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 176 | 122 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.13e-06 | 176 | 122 | 6 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-06 | 176 | 122 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 122 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.43e-06 | 177 | 122 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-06 | 177 | 122 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.01e-05 | 179 | 122 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-05 | 180 | 122 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 181 | 122 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.11e-05 | 182 | 122 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 1.18e-05 | 184 | 122 | 6 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 188 | 122 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.33e-05 | 188 | 122 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 188 | 122 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.33e-05 | 188 | 122 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 189 | 122 | 6 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 189 | 122 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 189 | 122 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.37e-05 | 189 | 122 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 189 | 122 | 6 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 190 | 122 | 6 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-05 | 191 | 122 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 191 | 122 | 6 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 122 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-05 | 191 | 122 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 191 | 122 | 6 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 191 | 122 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.50e-05 | 192 | 122 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 192 | 122 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 192 | 122 | 6 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 192 | 122 | 6 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 193 | 122 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.54e-05 | 193 | 122 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| Computational | Genes in the cancer module 85. | 2.93e-04 | 51 | 68 | 4 | MODULE_85 | |
| Computational | Genes in the cancer module 58. | 2.97e-04 | 21 | 68 | 3 | MODULE_58 | |
| Computational | Complement. | 3.92e-04 | 23 | 68 | 3 | MODULE_130 | |
| Computational | Genes in the cancer module 199. | 4.50e-04 | 57 | 68 | 4 | MODULE_199 | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.11e-06 | 197 | 121 | 9 | 1693_DN | |
| Drug | dermatan sulfate | 2.76e-06 | 220 | 121 | 9 | CID000032756 | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 3629_DN | |
| Disease | adhesion G protein-coupled receptor E2 measurement | 2.18e-07 | 4 | 113 | 3 | EFO_0021892 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.93e-05 | 14 | 113 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | tyrosine-protein kinase transmembrane receptor ROR2 measurement | 4.35e-05 | 3 | 113 | 2 | EFO_0803209 | |
| Disease | ectodysplasin-a, secreted form measurement | 4.35e-05 | 3 | 113 | 2 | EFO_0020341 | |
| Disease | thrombospondin type-1 domain-containing protein 7A measurement | 4.35e-05 | 3 | 113 | 2 | EFO_0803150 | |
| Disease | COVID-19 (is_implicated_in) | 6.92e-05 | 21 | 113 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 measurement | 8.68e-05 | 4 | 113 | 2 | EFO_0801407 | |
| Disease | pseudotumor cerebri | 1.33e-04 | 26 | 113 | 3 | EFO_1001132 | |
| Disease | bone disease (implicated_via_orthology) | 1.44e-04 | 5 | 113 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | insulin-like growth factor I measurement | 1.44e-04 | 5 | 113 | 2 | EFO_0801702 | |
| Disease | ERO1-like protein alpha measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801582 | |
| Disease | serine/threonine-protein kinase PAK 3 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020728 | |
| Disease | receptor-type tyrosine-protein kinase flt3 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020703 | |
| Disease | protocadherin beta-4 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801976 | |
| Disease | cytosolic non-specific dipeptidase measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020310 | |
| Disease | cyclin-dependent kinase 8:cyclin-c complex measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020297 | |
| Disease | zinc finger protein 276 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0802227 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0801372 | |
| Disease | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0020637 | |
| Disease | transmembrane protein 2 measurement | 2.16e-04 | 6 | 113 | 2 | EFO_0802155 | |
| Disease | triacylglycerol 54:3 measurement | 2.27e-04 | 31 | 113 | 3 | EFO_0010421 | |
| Disease | thyroxine measurement | 2.97e-04 | 83 | 113 | 4 | EFO_0005130 | |
| Disease | regulator of G-protein signaling 8 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0801997 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 3 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0020343 | |
| Disease | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0801881 | |
| Disease | BCL-2-like protein 1 measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0020177 | |
| Disease | uroplakin-3b-like protein measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0802204 | |
| Disease | kinesin-like protein KIF16B measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0801747 | |
| Disease | macrophage-stimulating protein receptor measurement | 3.01e-04 | 7 | 113 | 2 | EFO_0020550 | |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020813 | |
| Disease | stabilin-2 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020752 | |
| Disease | desmoglein-1 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020321 | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801513 | |
| Disease | zinc-alpha-2-glycoprotein measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0802228 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801373 | |
| Disease | opioid-binding protein/cell adhesion molecule measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020618 | |
| Disease | chromobox protein homolog 5 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0020258 | |
| Disease | kallikrein-6 measurement | 4.01e-04 | 8 | 113 | 2 | EFO_0801739 | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0803293 | |
| Disease | epididymal-specific lipocalin-10 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0801576 | |
| Disease | dickkopf-like protein 1 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020324 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0801514 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 1 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020342 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020296 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0801463 | |
| Disease | oxysterols receptor LXR-beta measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0801865 | |
| Disease | malaria (implicated_via_orthology) | 5.14e-04 | 9 | 113 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | apolipoprotein D measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020156 | |
| Disease | complement component C8 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0008094 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0801787 | |
| Disease | plexin-B2 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0021867 | |
| Disease | interleukin-34 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020505 | |
| Disease | kallikrein-14 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020513 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0021876 | |
| Disease | RNA-binding protein 24 measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0802030 | |
| Disease | heterogeneous nuclear ribonucleoprotein q measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0020443 | |
| Disease | Secreted frizzled-related protein 3 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0008277 | |
| Disease | serine/threonine-protein kinase 16 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0020724 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0801535 | |
| Disease | DNA repair protein rad51 homolog 1 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0020330 | |
| Disease | tropomyosin beta chain measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0020787 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 6.41e-04 | 10 | 113 | 2 | OBA_2045132 | |
| Disease | interleukin-37 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0801700 | |
| Disease | suicide behaviour | 6.46e-04 | 44 | 113 | 3 | EFO_0007623 | |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0020801 | |
| Disease | central corneal thickness, intraocular pressure measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0004695, EFO_0005213 | |
| Disease | interleukin-10 receptor subunit alpha measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0021890 | |
| Disease | guanylate-binding protein 6 measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0801662 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0801640 | |
| Disease | oncostatin-M measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 9.36e-04 | 12 | 113 | 2 | EFO_0020833 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0010592 | |
| Disease | kallikrein-12 measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0008194 | |
| Disease | tyrosine-protein phosphatase non-receptor type 1 measurement | 1.10e-03 | 13 | 113 | 2 | EFO_0020834 | |
| Disease | cortical thickness | A2M THSD4 CAPZA1 PCDHB11 FGFRL1 IRAG1 PCDHB16 SEMA3A ABCG1 COCH ROBO2 MUSK | 1.17e-03 | 1113 | 113 | 12 | EFO_0004840 |
| Disease | glycerate measurement | 1.48e-03 | 15 | 113 | 2 | EFO_0021029 | |
| Disease | Rhabdomyosarcoma | 1.48e-03 | 15 | 113 | 2 | C0035412 | |
| Disease | Malaria, susceptibility to | 1.68e-03 | 16 | 113 | 2 | cv:C1970028 | |
| Disease | – | 1.68e-03 | 16 | 113 | 2 | 611162 | |
| Disease | SLAM family member 7 measurement | 1.90e-03 | 17 | 113 | 2 | EFO_0008287 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.90e-03 | 17 | 113 | 2 | EFO_0021969 | |
| Disease | Age-related macular degeneration | 2.14e-03 | 18 | 113 | 2 | cv:C0242383 | |
| Disease | lysophosphatidylcholine 20:5 measurement | 2.38e-03 | 19 | 113 | 2 | EFO_0010364 | |
| Disease | squamous cell carcinoma (is_marker_for) | 2.38e-03 | 19 | 113 | 2 | DOID:1749 (is_marker_for) | |
| Disease | Malaria | 2.64e-03 | 20 | 113 | 2 | C0024530 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.49e-03 | 23 | 113 | 2 | C1335177 | |
| Disease | QRS duration, response to sulfonylurea | 3.49e-03 | 23 | 113 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.80e-03 | 24 | 113 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.80e-03 | 24 | 113 | 2 | C3805278 | |
| Disease | malaria (is_implicated_in) | 3.80e-03 | 24 | 113 | 2 | DOID:12365 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNLETKYKVCNYGLT | 56 | Q9Y277 | |
| TYQGKTLQGTSYQVT | 121 | A8MT66 | |
| KGYILVGQAKLSCSY | 456 | P04003 | |
| TCLGQQYYNETLGKT | 361 | Q14264 | |
| VGSGCVAQVYKAYAN | 206 | Q7Z695 | |
| QTYCAGPAYLKGQVV | 421 | P22792 | |
| QLYVLSQGQCVYRGK | 286 | P45844 | |
| KSYGTCVNTLGSYTC | 131 | Q9UHX3 | |
| GTALYYATQNCLGKA | 196 | Q13790 | |
| YSNGFCTVYAKTIDG | 136 | P52907 | |
| CTGNIGYTLYSSKPV | 196 | P31994 | |
| YTCLAGNSIGLSYQS | 331 | P22455 | |
| LCKSYGTCVNTLGSY | 126 | P48960 | |
| CYNGLVYVLKSNSGE | 831 | Q4L235 | |
| LQGGSAYKLVCYFTN | 21 | Q15782 | |
| GNVFEYGVKAVYTCN | 101 | P08603 | |
| TCYVALNVLKNGYLS | 151 | Q9UPY3 | |
| YYAGVNGISVVECLS | 321 | Q8TAM1 | |
| YQALCNIYGSITIGQ | 326 | Q9UHL0 | |
| GYIQCSQFLYGVQEK | 1001 | Q96KQ4 | |
| VTGEGCVYLQTSLKY | 1316 | P01023 | |
| VSYCGGFINSSIITK | 146 | Q8NH87 | |
| TLSQSYQYEVCLTGG | 746 | Q9Y5E7 | |
| TLSQSYQYEVCLTGG | 691 | Q96TA0 | |
| AGAKYTGYLCRSNTV | 731 | Q6ZW49 | |
| YTSAGISQYTVKGLQ | 176 | Q92637 | |
| KGNYTCVVENEYGSI | 226 | P21802 | |
| KTISYAGCTVQLYFV | 91 | Q9GZK6 | |
| GKYTCVASNIYGTVN | 121 | O75121 | |
| IQEYIGCYTSDSSGK | 1116 | Q9NU22 | |
| CGYYNTAVKLARQSG | 136 | Q7L5Y9 | |
| SVLAGQVNIYSCNYS | 981 | Q16787 | |
| KVTANIVFGYATCQG | 481 | Q9UDY8 | |
| GAALLYEYCQQKGIS | 116 | Q9H9P8 | |
| TYTVTAQGEKGLYQC | 486 | Q5VTL7 | |
| AAKYYSVQNLGICTP | 111 | Q8N6Q8 | |
| LALYETCEKYGLGSQ | 136 | Q8WX39 | |
| LLQSKYESYVQTGCT | 566 | Q9BVA0 | |
| VLTVVLGLYNSYNSC | 856 | Q9Y6F6 | |
| CTGNIGYTLYSSKPV | 196 | P31995 | |
| DGILCNTYIDSYKGT | 271 | Q53EL6 | |
| VYVCKATNGFGSLSV | 96 | Q8N441 | |
| YGNKSISFIGCGIQS | 86 | Q8NG80 | |
| IYDSGTYKCTVIVNN | 101 | P16284 | |
| TGQQFIYSGCSTGKV | 451 | Q8TEB1 | |
| FSCAFNYKGNIVITG | 391 | Q8N136 | |
| LQIVAICTNGLYGKY | 386 | P23471 | |
| ICTNGLYGKYSDQLI | 391 | P23471 | |
| TISYGGCITQLYVFL | 91 | O95371 | |
| KTISYGGCVVQFYIS | 91 | Q8N628 | |
| TLSQSYQYEVCLTGG | 746 | Q9UN67 | |
| GTGTLSQSYQYEVCL | 741 | Q9Y5E8 | |
| VSYCGGFINSSIITK | 146 | P0C7N8 | |
| YCYNSAKNSTVLQGV | 31 | O94886 | |
| GNKVISFAGCLTQYF | 86 | Q8NGE1 | |
| IYGALTSDTGKYTCV | 3306 | Q96RW7 | |
| SEGIQASVCYLYGKL | 191 | Q5TIA1 | |
| SSQKTISYGGCTVQY | 91 | Q5JQS5 | |
| GTGTLSQSYQYEVCL | 741 | Q9Y5F2 | |
| QHVDTGNSYLCGYLK | 146 | Q8IVV7 | |
| TAYLCGVKANFQTIG | 116 | P09923 | |
| YGNYTCVATNKLGNT | 291 | Q14982 | |
| GTGTLSQSYQYEVCL | 741 | Q9NRJ7 | |
| GTGTLSQSYQYEVCL | 741 | Q9Y5E9 | |
| GTLSQSYQYEVCLTG | 741 | Q9Y5E2 | |
| IETGKTNYNTCYTAG | 336 | Q92838 | |
| TNYNTCYTAGVCLLK | 341 | Q92838 | |
| ASATTLYGKVYICGG | 426 | Q6JEL2 | |
| GQSGICITFKYNQYE | 166 | Q8WZ79 | |
| IQFGSQIKYSCTKGY | 121 | P17927 | |
| ACNNKGYYTQISTLA | 446 | Q7Z3S7 | |
| FYHSCKQYGITGENV | 161 | Q96JB5 | |
| VGKNVVYTCNEGYSL | 591 | P10643 | |
| QGAIYTVEYACSAVK | 61 | Q96FH0 | |
| YYISANVTGFKCVTG | 196 | Q16739 | |
| AVICSGTYAQVYVQT | 986 | Q9UHN6 | |
| YKLTGLQQQCDDYGS | 346 | Q9BXX0 | |
| VYGNIVYASVSSICG | 61 | O43405 | |
| GSAYTYIVQRKNDSC | 551 | P46059 | |
| YSVCIFTYGQTGTGK | 476 | Q96AC6 | |
| AYGTVYCGLTSQGQL | 1071 | Q56UN5 | |
| GEYCQTRYVKTTGNA | 276 | Q06587 | |
| SISYGGCVVQLYISL | 91 | P59922 | |
| GTGTLSQSYQYEVCL | 741 | Q9Y5E6 | |
| SNCLGIYYFAKQIGA | 131 | Q3ZCT8 | |
| GTLSQSYQYKVCLTG | 741 | Q9Y5E3 | |
| SYQYKVCLTGGSETN | 746 | Q9Y5E3 | |
| GTGTLFQSYQYEVCL | 741 | Q9Y5E1 | |
| KQDLAGTYRCYGSVT | 91 | Q14954 | |
| TITYGGCVAQLYISL | 91 | Q8NGZ4 | |
| EGQYGKVYTCISVDT | 1351 | Q9Y6R4 | |
| KGCLQFLQSVYSTFG | 556 | A2RTX5 | |
| LNAAQTSVAYGCIKY | 491 | P54136 | |
| CQNIYLTTGYAGSKN | 246 | O15226 | |
| GIYVYLAGCSAQVVN | 671 | P58743 | |
| TANTNTCNKYGVSGY | 86 | P30101 | |
| YTSSLGYRKVVSNVC | 746 | Q96PQ0 | |
| YSISTGNKIITYNAC | 81 | A6NDL8 | |
| KGTEICNYSYSNTIL | 106 | Q9Y4P8 | |
| ALVGEKACYQSISSY | 466 | Q8N3P4 | |
| KACYQSISSYGGQIF | 471 | Q8N3P4 | |
| GYYQCVATNGMKTIT | 131 | Q01974 | |
| LKAYNQTHLYACGTG | 121 | Q14563 | |
| VAKGYNICLFAYGQT | 91 | Q9P2P6 | |
| SVNATSKTGGYLVYC | 501 | P46087 | |
| GNTGMAQTLLYTYCS | 871 | Q9Y5Q9 | |
| YYKCGAQFALVTLGT | 286 | O75027 | |
| YAVGSNSKTLRVCAY | 621 | O94967 | |
| QGEYLTYICLSVTNK | 41 | Q8NFX7 | |
| YKGGYNGLNQCLTTT | 126 | Q03936 | |
| VNLVIGTLYCAKGNY | 546 | Q8N4P2 | |
| QSEYCNVGTKTYLTN | 1941 | Q8IZQ1 | |
| CSLYSLGTGKNIYVE | 3031 | Q15413 | |
| TGEYICNQCGAKYTS | 631 | Q96K83 | |
| SYVTCTLGIQFVGYV | 281 | Q86WB7 | |
| CSVLYGKVSQYTGRA | 306 | Q86WB7 | |
| ISCRNVNGYSYKVAV | 111 | Q9BX74 | |
| HSKYGCTFIGNQDTY | 261 | Q6Q0C0 | |
| AGYYICQALTVAGSI | 386 | Q9HCK4 | |
| SGVLICSENYITYKN | 246 | Q15393 | |
| AGLYTTHTGQKFYQC | 136 | Q14588 | |
| VNLVIGTLYCAKGNY | 546 | Q86WT1 | |
| IKNVLGGSTCYNYSV | 1241 | Q86YA3 | |
| GGSTCYNYSVKDLQE | 1246 | Q86YA3 | |
| CSYSQGSVKRQALYA | 46 | Q8N806 | |
| QKYGTQGCYLLKINS | 216 | Q9Y2L5 | |
| QINCTYQTSGFYGLS | 36 | A0A0B4J248 | |
| STAISCIGAYRQYKL | 286 | Q6ZMP0 | |
| LSTAKGDVICYYGNR | 126 | Q6ICL3 | |
| YVTVSSTYSGKLCGL | 1276 | Q9Y493 | |
| GQYRCVAKNSLGTAY | 186 | O15146 | |
| VLYSTSGENASGKYC | 796 | Q9NZM1 | |
| TYAIAGYNATLNCSV | 1056 | Q00872 | |
| NYSGVYICKVTNSLG | 331 | Q9NQS3 |